Renal inflammation, autoimmunity and salt-sensitive hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 1, 2012, Pages 96-103

  Rodríguez Iturbe, Bernardo ^a   Franco, Martha ^b   Tapia, Edilia ^b   Quiroz, Yasmir ^a   Johnson, Richard J ^c  

^a HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

^b Department of Nephrology   (Mexico)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Heat shock proteins; Lymphocytes; Macrophages; Pressure natriuresis; T cells

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 70; INTERLEUKIN 17; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; N(G) NITROARGININE METHYL ESTER; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM CHLORIDE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; DAHL SALT SENSITIVE RAT; DISEASE ASSOCIATION; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; GENE EXPRESSION; HIGH SODIUM INTAKE; HORMONE ACTION; HUMAN; HYPERTENSION; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; KIDNEY TUBULE ABSORPTION; LYMPHOCYTE; MACROPHAGE; NATRIURESIS; NONHUMAN; OXIDATIVE STRESS; PSORIASIS; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SALT SENSITIVE HYPERTENSION; SODIUM BALANCE; SODIUM RETENTION; T CELL DEPLETION; T LYMPHOCYTE; THYMECTOMY;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYPERTENSION; KIDNEY TUBULES; MACROPHAGES; NATRIURESIS; NEPHRITIS; SODIUM CHLORIDE, DIETARY; T-LYMPHOCYTES;

EID: 84855164070     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05482.x     Document Type: Article

References (74)

1. Weinberg M, Fineberg N. Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension 1991; 18: 67-71.
2. Rodriguez-Iturbe B, Romero F, Johnson RJ. Pathophysiologic mechanisms of salt sensitive hypertension. Am. J. Kidney Dis. 2007; 50: 655-72.
3. Johnson RJ, Herrera J, Schreiner G, Rodríguez-Iturbe B. Acquired and subtle renal injury as a mechanism for salt-sensitive hypertension. Bridging the hypothesis of Goldblatt and Guyton. N. Engl. J. Med. 2007; 346: 913-23.
4. Rodriguez-Iturbe B, Johnson RJ. The role of renal microvascular disease and interstitial inflammation in salt-sensitive hypertension. Hypertens. Res. 2010; 33: 975-80.
5. Guyton AC. Blood pressure control: Special role of the kidneys and body fluids. Science 1991; 252: 1813-16.
6. Guyton AC, Coleman TG, Cowley AW Jr, Scheel KW, Manning RD Jr, Norman RA Jr. Arterial pressure regulation: Overriding dominance of the kidneys in long-term regulation and in hypertension. Am. J. Med. 1972; 52: 584-94.
7. Rodriguez-Iturbe B. Renal infiltration of immunocompetent cells: Cause and effect of sodium sensitive hypertension. Clin. Exp. Nephrol. 2010; 14: 105-11.
8. Vaziri ND, Rodriguez-Iturbe B. Mechanisms of cisease: Oxidative stress and inflammation in the pathogenesis of hypertension. Nat. Clin. Prac. Nephrol. 2006; 2: 582-93.
9. Tian N, Moore RS, Braddy S et al. Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am. J. Physiol. Heart Circ. Physiol. 2007; 293: H3388-95.
10. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension? Am. J. Physiol. Regul. Intergr. Comp. Physiol. 2005; 289: R913-35.
11. Johnson RJ, Gordon KL, Suga S, Duijvestijn AM, Griffin K, Bidani A. Renal injury and salt-sensitive hypertension after exposure to catecholamines. Hypertension 1999; 34: 151-9.
12. Raqy PE, Suga S, Lin X-H, Huang X, Johnson RJ. Chronic potassium depletion induces renal injury, salt-sensitivity and hypertension in young rats. Kidney Int. 2001; 59: 1850-8.
13. Bohle A, Muller G, Whermann M, Mackensen-Haen S, Xiao J-C. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies and chronic interstitial nephritides. Kidney Int. 1996; 49 (Suppl. 54): S2-9.
14. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002; 39: 316-22.
15. Cowley AW. Renal medullary oxidative stress, pressure-natriuresis and hypertension. Hypertension 2008; 52: 777-86.
16. Makino A, Skelton MM, Zou AP, Roman RJ, Cowley AW Jr. Increased renal medullary oxidative stress produces hypertension. Hypertension 2002; 39: 667-72.
17. Asghar M, Chug G, Lokhandwala MF. Infammation compromises renal dopamine D1 receptor function in rats. Am. J. Physiol. Renal Physiol. 2009; 297: F1543-9.
18. Kurokawa K. Kidney, salt and hypertension. How and why. Kidney Int. 1996; 49 (Suppl. 55): S46-51.
19. Quiroz Y, Pons H, Gordon KL et al. Mycophenolate mofetil prevents the salt-sensitive hypertension resulting from short-term nitric oxide synthesis inhibition. Am. J. Physiol. Renal Physiol. 2001; 281: F38-47.
20. Wang C-T, Chin SY, Navar LG. Impairment of pressure diuresis and renal autoregulation in Ang II-infused hypertensive rats. Am. J. Physiol. Renal Physiol. 2000; 279: F319-25.
21. Zhao D, Navar LG. Acute angiotensin infusions elicit pressure natriuresis in mice and reduce fractional sodium reabsorption. Hypertension 2008; 52: 137-42.
22. Schiffrin E. T lymphocytes: A role in hypertension? Curr. Opin. Nephrol. Hypertens. 2010; 18: 181-6.
23. Harrison DG, Guzik TJ, Goronzy J, Weyand C. Is hypertension an immunologic disease? Curr. Cardiol. Rep. 2008; 10: 464-9.
24. Bataillard P, Freiche J-C, Vincent M, Touraine J-L, Sassard JU. Effects of neonatal thymectomy on blood pressure and immunological characteristics of the genetically hypertensive rats of the Lyon strain. J. Hypertens. 1986; 4 (Suppl. 3): 5455-67.
25. Svendsen UG. Spontaneous hypertension and hypertensive vascular disease in the NZB strain of mice. Acta Pathol. Microbiol. Scand. A 1977; 85: 548-54.
26. Svendsen UG. Evidence for an initial, thymus independent and a chronic, thymus-dependent phase of DOCA and salt hypertension in mice. Acta Pathol. Microbiol. Scand. A 1976; 84: 523-8.
27. Svendsen UG. The importance of thymus in the pathogenesis of the chronic phase of hypertension in mice following partial infarction of the kidney. Acta Pathol. Microbiol. Scand. A 1977; 85: 539-47.
28. Bendich A, Belisle EH, Strausser HR. Immune system modulation and its effects on blood pressure of the spontaneously hypertensive male and female rat. Biochem. Biophys. Res. Commun. 1981; 99: 600-7.
29. Guzik TJ, Hoch NE, Brown KA et al. Role of the T-cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 2007; 204: 2449-60.
30. Lee DL, Sturgis LC, Labazi H et al. Angiotensin II hypertension in attenuated in interleukin-γ knockout mice. Am. J. Physiol. Heart Circ. Physiol. 2006; 290: H935-40.
31. Rodríguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Mezzano S, Vaziri ND. Early and sustained inhibition of nuclear factor kappa B prevents hypertension in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 2005; 315: 51-7.
32. Müller DN, Dechend R, Mervaal EMA et al. NF-kB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 2000; 35: 193-201.
33. Rodríguez-Iturbe B, Quiroz Y, Nava M et al. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am. J. Physiol. Renal Physiol. 2002; 282: F191-201.
34. Mattson DL, James L, Berdan EA, Meister CJ. Immune suppression attenuates hypertension and renal disease in Dahl salt-hypertensive rats. Hypertension 2006; 48: 149-56.
35. Tian N, Gu JW, Braddy SJ, Rose RA, Hughson MD, Manning RD Jr. Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Am. J. Physiol. Heart Circ. Physiol. 2007; 292: H1018-25.
36. Rodríguez-Iturbe B, Pons H, Quiroz Y et al. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int. 2001; 59: 2222-32.
37. Bravo Y, Quiroz Y, Pons H et al. Vimentin and heat shock protein expression are induced in the kidney by angiotensin and by nitric oxide inhibition. Kidney Int. 2003; 64 (Suppl. 86): S46-51.
38. Alvarez V, Quiroz Y, Nava M, Pons H, Rodríguez-Iturbe B. Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am. J. Physiol. Renal Physiol. 2002; 283: F1132-41.
39. Vanegas V, Ferrebuz A, Quiroz Y, Rodríguez-Iturbe B. Hypertension in page (cellophane wrapped) kidney is due to interstitial nephritis. Kidney Int. 2005; 68: 1161-70.
40. Stewart T, Jung FF, Manning J, Vehaskari VM. Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension. Kidney Int. 2005; 68: 2180-8.
41. Mervaala E, Müller DN, Park J-K et al. Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes. Hypertension 2000; 35: 360-6.
42. Khraibi AA, Norman RA Jr, Dzielak DJ. Chronic immunosuppression attenuates hypertension in Okamoto spontaneously hypertensive rats. Am. J. Physiol. 1984; 247: H722-6.
43. Rodríguez-Iturbe B, Zhan C-D, Quiroz Y, Sindhu RK, Vaziri ND. Antioxidant-rich diet improves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 2003; 41: 341-6.
44. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 2001; 37: 781-6.
45. Nava M, Quiroz Y, Vaziri ND, Rodríguez-Iturbe B. Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. 2003; 284: F447-54.
46. Crosswhite P, Sun Z. Ribonucleic acid interference knockdown of interleukin 6 attenuates cold-induced hypertension. Hypertension 2010; 55: 1484-91.
47. Shao J, Nangaku M, Miyata T et al. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003; 42: 31-8.
48. Gratze P, Dechend R, Stocker C et al. Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension. Circulation 2008; 117: 2645-56.
49. Viel EC, Lamarié CA, Benkirane K, Paradis P, Schiffrin EL. Immune regulation and vascular inflammation in genetic hypertension. Am. J. Physiol. Heart Circ. Physiol. 2009; 298: H938-44.
50. Kvakan H, Kleinewietfeld M, Qadri F et al. Regulatory T-cells ameliorate angiotensin II-induced cardiac damage. Circulation 2009; 119: 2904-12.
51. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA study. Am. J. Hypertens. 2004; 17: 568-73.
52. Herrera J, Ferrebuz A, MacGregor EG, Rodriguez-Iturbe B. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J. Am. Soc. Nephrol. 2006; 17 (Suppl. 3): S218-25.
53. Hughson MD, Gobe GC, Hoy WE, Manning RD Jr, Douglas-Denton R, Bertram JF. Associations of glomerular number and birth weight with clinicopathological features of African Americans and whites. Am. J. Kidney Dis. 2008; 52: 18-28.
54. Sommers SC, Relman AS, Smithwick RH. Histologic studies of kidney biopsy specimens from patients with hypertension. Am. J. Pathol. 1958; 34: 685-715.
55. Jurewicz M, McDermott DH, Sechler JL et al. Human T and natural killer cells posses a functional renin-angiotensin system: Further mechanisms of angiotensin II-induced inflammation. J. Am. Soc. Nephrol. 2007; 18: 1093-102.
56. Hotch NE, Guzik TJ, Chen W et al. Regulation of T-cell function by endogenously produced angiotensin II. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009; 296: R208-16.
57. Franco M, Martínez F, Quiroz Y et al. Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am. J. Physiol. Regul. Intergr. Comp. Physiol. 2007; 293: R251-6.
58. De Miguel C, Das S, Lund H, Mattson DL. T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am. J. Physiol. Regul. Intergr. Comp. Physiol. 2010; 298: R1136-42.
59. Lob HE, Marvar PJ, Guzik TJ et al. Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension 2010; 55: 277-83.
60. Machnik A, Neuhofer W, Jantsch J et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C dependent buffering mechanism. Nat. Med. 2009; 15: 545-52.
61. Machnik A, Dhalmann A, Kopp C et al. Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhyancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats. Hypertension 2010; 55: 755-61.
62. Norman RA Jr, Galloway PG, Dzielak DJ, Huang M. Mechanisms of partial renal infarct hypertension. J. Hypertens. 1988; 6: 397-403.
63. Ba D, Takeichi N, Kodama T, Kobayashi H. Restoration of T-cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts. J. Immunol. 1982; 128: 1211-16.
64. Tuttle RS, Boppana DP. Antihypertensive effect of interleukin 2. Hypertension 1990; 15: 89-94.
65. Dzielak DJ. AIDS, lupus, rheumatoid arthritis-hypertension? Hypertension 1990; 15: 95-6.
66. Kristensen BO, Andersen PL. Autoantibodies in untreated and treated essential hypertension. Acta Med. Scand. 1978; 203: 55-9.
67. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells and salt-sensitive hypertension. All for one and one for all. Am. J. Physiol. Renal Physiol. 2004; 286: F606-16.
68. Kaufmann SHE. Heat shock proteins and the immune response. Immunol. Today 1990; 11: 129-36.
69. Young RA. Stress proteins and immunology. Annu. Rev. Immunol. 1990; 8: 401-20.
70. Ishizaka N, Aizawa T, Ohno M et al. Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of angiotensin II. Hypertension 2002; 39: 122-8.
71. Parra G, Quiroz Y, Salazar J et al. Experimental induction of salt-sensitive hypertension is associated with lymphocyte proliferative response to HSP70. Kidney Int. Suppl. 2008; 111: S55-9.
72. Pockley AG, De Faire U, Kiessling R, Lemne C, Thulin T, Frostegård J. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J. Hypertens. 2002; 20: 1815-20.
73. Miossec P, Kom T, Kuchroo VK. Interleukin-17 and Type 17 helper T-cells. N. Engl. J. Med. 2009; 361: 888-98.
74. Madhur MS, Lob HE, McCann LA et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010; 55: 500-7.